Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44)
Funding Opportunity Number: RFA-HL-14-012 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.23393.35093.83793.838Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Jun 19, 2015Award Ceiling: Expected Number of Awards: Creation Date: Apr 16, 2013Funding Opportunity Description: The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal o...
Source: Grants.gov - April 18, 2013 Category: Research Tags: Health Source Type: funding
Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44)
Funding Opportunity RFA-HL-14-012 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is to de-risk these technologies so that development can continue with private funding after NHLBI support ends; therefore, applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the project per...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 16, 2013 Category: Research Source Type: funding
Request for Proposals: National Organization for Rare Disorders Research Grant Program
NORD is offering the following seed grant funding opportunities in 2013: Adult Primary Lateral Sclerosis (PLS) Dubowitz Syndrome (DS) Glycine Encephalopathy, aka Nonketotic Hyperglycinemia (NKH) Growth Failure in Children with Cardiofaciocutaneous Syndrome (CFC) Post-Orgasmic Illness Syndrome (POIS) Pseudomyxoma Peritonei (PMP) (Two grants) A letter of intent is due to NORD by May 15, 2013. Invitations to submit a full proposal will be sent in early July and these full proposals will be due by September 11, 2013. The NORD Research Grant Program provides seed-money grants to academic sci...
Source: ScanGrants feed - April 16, 2013 Category: Research Authors: National Organization for Rare Disorders Source Type: funding
Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)
Funding Opportunity Number: PAR-13-128 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.23393.83793.83893.839Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) st...
Source: Grants.gov - March 2, 2013 Category: Research Tags: Health Source Type: funding
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)
Funding Opportunity Number: RFA-AR-14-005 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.846Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Aug 01, 2013Award Ceiling: $225,000Expected Number of Awards: Creation Date: Mar 01, 2013Funding Opportunity Description: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treat...
Source: Grants.gov - March 2, 2013 Category: Research Tags: Health Source Type: funding
Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)
Funding Opportunity RFA-AR-14-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic or skin diseases. Rare diseases have a prevalence of fewer than 200,000 affected individuals in the United States. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic or skin diseases....
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 1, 2013 Category: Research Source Type: funding
Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)
Funding Opportunity PAR-13-128 from the NIH Guide for Grants and Contracts. The support of multi-site clinical trials is one strategy NHLBI uses to improve the understanding of the clinical mechanisms of disease and to improve prevention, diagnosis, and treatment. The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for submitting grant applications for investigator-initiated multi-site randomized controlled clinical trials. The trials may address any research question related to the mission and goals of the NHLBI and may test clinical or behavioral interventions. The FOA is appropriate ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 1, 2013 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement (FOA) for The Rare Diseases Clinical Research Consortia (U54)
Notice NOT-TR-13-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2013 Category: Research Source Type: funding
Gene Function Studies to Investigate Rare and Undiagnosed Diseases (Admin Supp)
Funding Opportunity Number: PA-13-076 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.310Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, ...
Source: Grants.gov - January 8, 2013 Category: Research Tags: Health Source Type: funding
Gene Function Studies to Investigate Rare and Undiagnosed Diseases (Admin Supp)
Funding Opportunity PA-13-076 from the NIH Guide for Grants and Contracts. This Administrative Supplement Program intends to support gene function studies in collaboration with the NIH Undiagnosed Diseases Program (UDP) to investigate the underlying genetics, biochemistry and pathophysiology of newly diagnosed diseases identified through the UDP. In recent years, gene function studies combined with genetic and genomic analyses and metabolic studies have greatly improved diagnoses of these very rare diseases and advanced scientific knowledge of the underlying pathogenesis. This initiative is funded through the NIH Com...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 7, 2013 Category: Research Source Type: funding
National Tay-Sachs & Allied Diseases Association Request for Proposals
National Tay-Sachs & Allied Diseases Association Request for Proposals The National Tay-Sachs & Allied Diseases Association Inc. (NTSAD) is considered to be the nation’s oldest genetic disease nonprofit organization. The “Allied Diseases” represent a family of almost 100 rare diseases including lysosomal storage diseases (LSD) and leukodystrophies affecting the central nervous system. A major element of NTSAD’s mission is to lead the fight to treat and cure Tay-Sachs, Canavan and related genetic diseases; therefore, NTSAD is committed to funding research projects that advance this missio...
Source: ScanGrants feed - January 3, 2013 Category: Research Authors: National Tay-Sachs & Allied Diseases Association Source Type: funding
